| 000 | 00985 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250512020218.0 | ||
| 264 | 0 | _c19891024 | |
| 008 | 198910s 0 0 eng d | ||
| 022 | _a0030-2414 | ||
| 024 | 7 |
_a10.1159/000226733 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGiaccone, G | |
| 245 | 0 | 0 |
_aPhase II study of esorubicin in the treatment of patients with advanced sarcoma. _h[electronic resource] |
| 260 |
_bOncology _c1989 |
||
| 300 |
_a285-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAntibiotics, Antineoplastic |
| 650 | 0 | 4 |
_aDoxorubicin _xanalogs & derivatives |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 |
_aFibroma _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOsteosarcoma _xdrug therapy |
| 650 | 0 | 4 |
_aSarcoma _xdrug therapy |
| 700 | 1 | _aDonadio, M | |
| 700 | 1 | _aCalciati, A | |
| 773 | 0 |
_tOncology _gvol. 46 _gno. 5 _gp. 285-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000226733 _zAvailable from publisher's website |
| 999 |
_c2785810 _d2785810 |
||